Stephen R. Brady, EVP, Strategy & Finance at Immune Design Corp. (IMDZ), sold 1,642 shares at $5.35 ($9K) on 2017-01-04, disclosed to the SEC on 2017-01-06.
Scheduled sale ($9k) by EVP, Strategy & Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| IMDZ | SELL | 2018-01-08 | $14K | — | Filing → |
| IMDZ | BUY | 2016-07-19 | $10K | — | Filing → |